Thalidomide-O-amido-PEG2-C2-NH2 TFA NEW
| Price | $45 | $65 | $110 |
| Package | 5mg | 10mg | 25mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2025-07-12 |
Product Details
| Product Name: Thalidomide-O-amido-PEG2-C2-NH2 TFA | CAS No.: 1957235-75-4 |
| Purity: 95.74% | Supply Ability: 10g |
| Release date: 2025/07/12 |
Product Introduction
Bioactivity
| Name | Thalidomide-O-amido-PEG2-C2-NH2 TFA |
| Description | Thalidomide-O-amido-PEG2-C2-NH2 TFA (E3 Ligase Ligand-Linker Conjugates 24 TFA) is a synthesized E3 ligase ligand-linker conjugate incorporating the Thalidomide-based cereblon ligand and a 2-unit PEG linker, utilized in PROTAC technology. |
| In vitro | PROTACs consist of two ligands linked together: one binds to an E3 ubiquitin ligase, and the other targets a specific protein. By leveraging the intracellular ubiquitin-proteasome system, PROTACs facilitate the selective degradation of target proteins [1]. |
| Storage | keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility Information | H2O : 150 mg/mL (260.2 mM), Sonication is recommended. |
| Keywords | Thalidomide-O-amido-PEG2-C2-NH2 TFA | Thalidomide-O-amido-PEG-2-C2-NH2 TFA | ThalidomideOamidoPEG2C2NH2 TFA | Thalidomide O amido PEG2 C2 NH2 TFA | Inhibitor | inhibit | E3LigaseLigandLinkerConjugate | E3 Ligase Ligand-Linker Conjugates 24 | E3 Ligase Ligand-Linker Conjugates | E3 Ligase Ligand-Linker Conjugate | E3 Ligase LigandLinker Conjugate | Cereblon Ligand-Linker Conjugates 10 | Cereblon |
| Inhibitors Related | (S,R,S)-AHPC-PEG2-NH2 hydrochloride | Thalidomide-O-C4-NH2 hydrochloride | Thalidomide-O-amido-C6-NH2 hydrochloride | Thalidomide-O-amido-PEG3-C2-NH2 TFA | Thalidomide 4'-ether-alkylC2-amine hydrochloride | (S,R,S)-AHPC-PEG3-N3 | Thalidomide-NH-C2-PEG3-OH | Thalidomide-NH-C4-NH-Boc | Pomalidomide 4'-PEG3-azide | Thalidomide-O-amido-C4-NH2 TFA | Thalidomide-O-C6-NH2 hydrochloride | Pomalidomide-C2-NH2 hydrochloride |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $82.00/2mg |
VIP3Y
|
TargetMol Chemicals Inc.
|
2025-07-18 | |
| $0.00/100mg |
VIP2Y
|
Xian confluore Biological Technology Co., Ltd.
|
2024-04-01 | |
| $0.00/25kg |
VIP1Y
|
Shaanxi Dideu New Materials Co. Ltd
|
2025-03-08 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY